Northwestern Kellogg logo

Take Action

Home | Faculty & Research Overview | Research

Research Details

Crestor

Abstract

AstraZeneca is preparing for the launch of Crestor, the company's first entrant in the enormous and fast growing statin category. The team responsible for the product launch is considering how best to bring Crestor to market. Should AstraZeneca simply follow the example set by Pfizer with the exceptionally successful launch of Lipitor? Or should the company instead launch Crestor as a niche product? The primary focus of the case is new product strategy. The case is unique because it can be used to teach new product strategy for both emerging and established categories. The case can also be used to teach competitive strategy.

Type

Case

Author(s)

Timothy Calkins, Joshua Neiman

Date Published

01/01/2006

Citations

Calkins, Timothy, and Joshua Neiman. Crestor. Case 5-306-506 (KEL245).

PREVIEW or BUY
KELLOGG INSIGHT

Explore leading research and ideas

Find articles, podcast episodes, and videos that spark ideas in lifelong learners, and inspire those looking to advance in their careers.
learn more

COURSE CATALOG

Review Courses & Schedules

Access information about specific courses and their schedules by viewing the interactive course scheduler tool.
LEARN MORE

DEGREE PROGRAMS

Discover the path to your goals

Whether you choose our Full-Time, Part-Time or Executive MBA program, you’ll enjoy the same unparalleled education, exceptional faculty and distinctive culture.
learn more